197 related articles for article (PubMed ID: 19857502)
1. Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.
Nowak-Sliwinska P; Ballini JP; Wagnières G; van den Bergh H
Microvasc Res; 2010 Jan; 79(1):21-8. PubMed ID: 19857502
[TBL] [Abstract][Full Text] [Related]
2. Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.
Nowak-Sliwinska P; van Beijnum JR; van Berkel M; van den Bergh H; Griffioen AW
Angiogenesis; 2010 Dec; 13(4):281-92. PubMed ID: 20842454
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibition by the maleimide-based small molecule GNX-686.
Nowak-Sliwinska P; Storto M; Cataudella T; Ballini JP; Gatz R; Giorgio M; van den Bergh H; Plyte S; Wagnières G
Microvasc Res; 2012 Mar; 83(2):105-10. PubMed ID: 22056402
[TBL] [Abstract][Full Text] [Related]
4. Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide.
Jacoby DB; Dyskin E; Yalcin M; Kesavan K; Dahlberg W; Ratliff J; Johnson EW; Mousa SA
Anticancer Res; 2010 Jan; 30(1):39-46. PubMed ID: 20150615
[TBL] [Abstract][Full Text] [Related]
5. Pluronic F127 as a drug vehicle used in chick embryo chorioallantoic membrane shell-less model.
Shi T; Li Z; Zhang Q; Zheng D; Li Z
Pak J Pharm Sci; 2015 Nov; 28(6):1997-9. PubMed ID: 26639476
[TBL] [Abstract][Full Text] [Related]
6. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
[TBL] [Abstract][Full Text] [Related]
7. The use of quantum dots for analysis of chick CAM vasculature.
Smith JD; Fisher GW; Waggoner AS; Campbell PG
Microvasc Res; 2007 Mar; 73(2):75-83. PubMed ID: 17070560
[TBL] [Abstract][Full Text] [Related]
8. The gelatin sponge-chorioallantoic membrane assay.
Ribatti D; Nico B; Vacca A; Presta M
Nat Protoc; 2006; 1(1):85-91. PubMed ID: 17406216
[TBL] [Abstract][Full Text] [Related]
9. Automated computational framework of blood vessel quantification in chick chorioallantoic membrane angiogenesis.
Shi P; Hong J; Huang Y; Zhang Z; Zhang M; Zhang L
J Biomed Opt; 2014; 19(10):106005. PubMed ID: 25277148
[TBL] [Abstract][Full Text] [Related]
10. Development of collateral vessels: A new paradigm in CAM angiogenesis model.
Gatne DP; Mungekar S; Addepalli V; Mohanraj K; Ghone SA; Rege NN
Microvasc Res; 2016 Jan; 103():11-3. PubMed ID: 26390964
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide.
McKay TL; Gedeon DJ; Vickerman MB; Hylton AG; Ribita D; Olar HH; Kaiser PK; Parsons-Wingerter P
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1184-90. PubMed ID: 18326748
[TBL] [Abstract][Full Text] [Related]
12. In ovo leptin administration inhibits chorioallantoic membrane angiogenesis in female chicken embryos through the STAT3-mediated vascular endothelial growth factor (VEGF) pathway.
Su L; Rao K; Guo F; Li X; Ahmed AA; Ni Y; Grossmann R; Zhao R
Domest Anim Endocrinol; 2012 Jul; 43(1):26-36. PubMed ID: 22417645
[TBL] [Abstract][Full Text] [Related]
13. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
14. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of vascular colonisation and angio-conduction in porous silicon-substituted hydroxyapatite with various pore shapes in a chick chorioallantoic membrane (CAM) model.
Magnaudeix A; Usseglio J; Lasgorceix M; Lalloue F; Damia C; Brie J; Pascaud-Mathieu P; Champion E
Acta Biomater; 2016 Jul; 38():179-89. PubMed ID: 27131570
[TBL] [Abstract][Full Text] [Related]
16. Capillary sprouts restrict macromolecular extravasation during normal angiogenesis in the chick chorioallantoic membrane.
Rizzo V; DeFouw DO
Microvasc Res; 1996 Jul; 52(1):47-57. PubMed ID: 8812754
[TBL] [Abstract][Full Text] [Related]
17. The chick chorioallantoic membrane as an in vivo angiogenesis model.
Ponce ML; Kleinmann HK
Curr Protoc Cell Biol; 2003 May; Chapter 19():Unit 19.5. PubMed ID: 18228425
[TBL] [Abstract][Full Text] [Related]
18. Effects of antibodies to EG-VEGF on angiogenesis in the chick embryo chorioallantoic membrane.
Feflea S; Cimpean AM; Ceausu RA; Gaje P; Raica M
In Vivo; 2012; 26(5):793-7. PubMed ID: 22949592
[TBL] [Abstract][Full Text] [Related]
19. [Effects of platelet-derived membrane microparticles on angiogenesis in chick chorioallantoic membranes].
Chen BA; Zhong YJ; Huang CY; Li CP; Shi GY; Xiao JY; Tang RC; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Ma Y; Song HH; Fei F; Pei XP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1070-3. PubMed ID: 17956693
[TBL] [Abstract][Full Text] [Related]
20. Avian area vasculosa and CAM as rapid in vivo pro-angiogenic and antiangiogenic models.
Makanya AN; Styp-Rekowska B; Dimova I; Djonov V
Methods Mol Biol; 2015; 1214():185-96. PubMed ID: 25468605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
